Clinical and laboratory interpretation of mitochondrial mRNA variants
- 11 July 2020
- journal article
- research article
- Published by Wiley in Human Mutation
- Vol. 41 (10) , 1783-1796
Abstract
Interpretation of mitochondrial protein‐encoding (mt‐mRNA) variants has been challenging due to mitochondrial characteristics that have not been addressed by American College of Medical Genetics and Genomics guidelines. We developed criteria for the interpretation of mt‐mRNA variants via literature review of reported variants, tested and refined these criteria by using our new cases, followed by interpreting 421 novel variants in our clinical database using these verified criteria. A total of 32 of 56 previously reported pathogenic (P) variants had convincing evidence for pathogenicity. These variants are either null variants, well‐known disease‐causing variants, or have robust functional data or strong phenotypic correlation with heteroplasmy levels. Based on our criteria, 65.7% (730/1,111) of variants of unknown significance (VUS) were reclassified as benign (B) or likely benign (LB), and one variant was scored as likely pathogenic (LP). Furthermore, using our criteria we classified 2, 12, and 23 as P, LP, and LB, respectively, among 421 novel variants. The remaining stayed as VUS (91.2%). Appropriate interpretation of mt‐mRNA variants is the basis for clinical diagnosis and genetic counseling. Mutation type, heteroplasmy levels in different tissues of the probands and matrilineal relatives, in silico predictions, population data, as well as functional studies are key points for pathogenicity assessments.Keywords
This publication has 36 references indexed in Scilit:
- Mutations in mitochondrially encoded complex I enzyme as the second common cause in a cohort of Chinese patients with mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodesJournal of Human Genetics, 2011
- Identification of novel mutations in five patients with mitochondrial encephalomyopathyBiochimica et Biophysica Acta (BBA) - Bioenergetics, 2009
- Haplogroup Effects and Recombination of Mitochondrial DNA: Novel Clues from the Analysis of Leber Hereditary Optic Neuropathy PedigreesThe American Journal of Human Genetics, 2006
- Bioenergetics of mitochondrial diseases associated with mtDNA mutationsBiochimica et Biophysica Acta (BBA) - Bioenergetics, 2004
- Mitochondrial DNA haplogroup distribution within Leber hereditary optic neuropathy pedigreesJournal of Medical Genetics, 2004
- Mitochondrial DNA C4171A/ND1 is a novel primary causative mutation of Leber's hereditary optic neuropathy with a good prognosisAnnals of Neurology, 2002
- Leber hereditary optic neuropathy: Does heteroplasmy influence the inheritance and expression of the G11778A mitochondrial DNA mutation?American Journal of Medical Genetics, 2001
- Intragenic Inversion of mtDNA: A New Type of Pathogenic Mutation in a Patient with Mitochondrial MyopathyThe American Journal of Human Genetics, 2000
- A mitochondrial DNA microdeletion in a newborn girl with transient lactic acidosisJournal of Inherited Metabolic Disease, 1996
- Bilateral striatal necrosis with a novel point mutation in the mitochondrial ATPase 6 genePediatric Neurology, 1995